Cardiovascular Revascularization Medicine
Volume 9, Issue 2 , Pages 66-70, April 2008

The relationship between severity of coronary artery disease and plasma level of vascular endothelial growth factor

  • Yasar Kucukardali

      Affiliations

    • Department of Internal Medicine, Gulhane School of Medicine, Haydarpasha Training Hospital, Istanbul, Turkey
    • Corresponding Author InformationCorresponding Author. GATA Haydarpasa Egitim Hastanesi, Ic Hastaliklari Servisi, Istanbul, Turkey. Tel.: +90 216 542 32 13; fax: +90 216 348 78 80.
  • ,
  • Sebnem Aydogdu

      Affiliations

    • Department of Internal Medicine, Gulhane School of Medicine, Haydarpasha Training Hospital, Istanbul, Turkey
  • ,
  • Namik Ozmen

      Affiliations

    • Department of Cardiology, Gulhane School of Medicine, Haydarpasha Training Hospital, Istanbul, Turkey
  • ,
  • Arif Yonem

      Affiliations

    • Department of Endocrinology, Gulhane School of Medicine, Haydarpasha Training Hospital, Istanbul, Turkey
  • ,
  • Emrullah Solmazgul

      Affiliations

    • Department of Internal Medicine, Gulhane School of Medicine, Haydarpasha Training Hospital, Istanbul, Turkey
  • ,
  • Mustafa Ozyurt

      Affiliations

    • Department of Microbiology, Gulhane School of Medicine, Haydarpasha Training Hospital, Istanbul, Turkey
  • ,
  • Yilmaz Cingozbay

      Affiliations

    • Department of Cardiology, Gulhane School of Medicine, Haydarpasha Training Hospital, Istanbul, Turkey
  • ,
  • Aydogan Aydogdu

      Affiliations

    • Department of Internal Medicine, Gulhane School of Medicine, Haydarpasha Training Hospital, Istanbul, Turkey

Received 3 October 2007; accepted 15 November 2007.

Abstract 

Objective

It has been known that ischemia or occlusion of coronary arteries in animal models increases the production of vascular endothelial growth factor (VEGF); however, little is known about the relationship between coronary artery disease and VEGF in humans. In this study, our aim was to evaluate the relationships between the degree of coronary occlusion and plasma VEGF level as well as other risk factors, including age, weight, arterial blood pressure, cholesterol, triglyceride, blood glucose, and high-sensitive C-reactive protein (hsCRP) in patients with established coronary artery disease.

Materials and Methods

Our study group consisted of 77 patients. Of these, 38 patients had normal coronary angiography (control group; group C) and 39 had abnormal angiography (17 critical lesion; group CL, 22 noncritical lesion; non-CL group).

Results

Plasma VEGF level was 116.95±30.12 pg/ml in the control group, 212.47±75.28 pg/ml in group CL, and 138.89±45.18 pg/ml in the non-CL group. Plasma VEGF level of group C was found to be lower than that of group CL (P<.05), but the difference between groups C and non-CL was insignificant (P>.05). However, logistic regression analysis showed that VEGF level of group CL was significantly higher (P<.001). There was a negative correlation between VEGF and haemoglobin (r=−0.58, P<.01), and positive correlation between VEGF and age (r=0.29, P<.04). There was no relationship between plasma VEGF level and other cardiac risk parameters. Group CL had a higher level of total and LDL-cholesterol levels.

Conclusion

Increased plasma VEGF levels in patients with coronary artery disease may point that the coronary lesion is critical, and VEGF increase in patients with established coronary artery disease may be used as an indicator of the need for revascularization.

Keywords: Coronary artery disease, Severity, Angiography, VEGF

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1553-8389(07)00335-1

doi:10.1016/j.carrev.2007.11.005

Cardiovascular Revascularization Medicine
Volume 9, Issue 2 , Pages 66-70, April 2008